Effekter av sedering med dexmedetomidin och butorfanol på hudreaktivitet vid intradermaltest på friska hundar

The effects of dexmedetomidine and butorphanol sedation on skin reactivity during intradermal testing in healthy dogs were evaluated. The effects of dexmedetomidine and butorphanol were compared to medetomidine, a sedative agent having scientific proof of not interfering with skin test reactivity, i...

Full description

Bibliographic Details
Main Author: Dahlheim, Anna
Format: L3
Language:Swedish
Inglés
Published: SLU/Dept. of Clinical Sciences (until 231231) 2010
Subjects:
_version_ 1855570224720379904
author Dahlheim, Anna
author_browse Dahlheim, Anna
author_facet Dahlheim, Anna
author_sort Dahlheim, Anna
collection Epsilon Archive for Student Projects
description The effects of dexmedetomidine and butorphanol sedation on skin reactivity during intradermal testing in healthy dogs were evaluated. The effects of dexmedetomidine and butorphanol were compared to medetomidine, a sedative agent having scientific proof of not interfering with skin test reactivity, in a randomised, double blind, cross over study performed on 8 adult dogs. The dogs were sedated with medetomidine (Domitor vet.®, 0,01 ml kg-1) intravenously, or dexmedetomidine and butorphanol intramuscularly (Dexdomitor vet.®, 0,01 ml kg-1; Dolorex vet., 0,01 ml kg-1) after which they received intradermal injections of positive control solutions (histamine 0,1 mg ml-1, 0,05 mg ml-1, 0,025 mg ml-1), a negative control solution (0,9 % NaCl) and allergen extract (Dermatophagoides farinae, Cladosporium and Artemisia vulgaris). After a wash out period the trial was repeated with a reversed sedation protocol. Skin reactivity (wheal size, induration and erythema) and quality of sedation (immobilization, response to stimuli and injections as well as over all working conditions) were evaluated. The combination of dexmedetomidine and butorphanol provided reliable, good sedation and analgesia without adverse effects. The study indicates that dexmedetomidine and butorphanol do not affect skin reactivity during intradermal testing in healthy dogs. In addition, only minor response to stimuli was noticed with dexmedetomidine and butorphanol and the combination provided immobilization superior to medetomidine sedation, thus better over all working conditions during intradermal testing compared to medetomidine. The study results indicate that dexmedetomidine and butorphanol sedation is very suitable for intradermal testing in dogs.
format L3
id RepoSLU775
institution Swedish University of Agricultural Sciences
language swe
Inglés
publishDate 2010
publishDateSort 2010
publisher SLU/Dept. of Clinical Sciences (until 231231)
publisherStr SLU/Dept. of Clinical Sciences (until 231231)
record_format eprints
spelling RepoSLU7752012-04-20T14:10:54Z Effekter av sedering med dexmedetomidin och butorfanol på hudreaktivitet vid intradermaltest på friska hundar Effects of dexmedetomidine and butorphanol sedation on intradermal test reactivity in healthy dogs Dahlheim, Anna Hund Allergi Atopisk dermatit Atopi Intradernaltest Sedering Dexmedetomidin Butorfanol The effects of dexmedetomidine and butorphanol sedation on skin reactivity during intradermal testing in healthy dogs were evaluated. The effects of dexmedetomidine and butorphanol were compared to medetomidine, a sedative agent having scientific proof of not interfering with skin test reactivity, in a randomised, double blind, cross over study performed on 8 adult dogs. The dogs were sedated with medetomidine (Domitor vet.®, 0,01 ml kg-1) intravenously, or dexmedetomidine and butorphanol intramuscularly (Dexdomitor vet.®, 0,01 ml kg-1; Dolorex vet., 0,01 ml kg-1) after which they received intradermal injections of positive control solutions (histamine 0,1 mg ml-1, 0,05 mg ml-1, 0,025 mg ml-1), a negative control solution (0,9 % NaCl) and allergen extract (Dermatophagoides farinae, Cladosporium and Artemisia vulgaris). After a wash out period the trial was repeated with a reversed sedation protocol. Skin reactivity (wheal size, induration and erythema) and quality of sedation (immobilization, response to stimuli and injections as well as over all working conditions) were evaluated. The combination of dexmedetomidine and butorphanol provided reliable, good sedation and analgesia without adverse effects. The study indicates that dexmedetomidine and butorphanol do not affect skin reactivity during intradermal testing in healthy dogs. In addition, only minor response to stimuli was noticed with dexmedetomidine and butorphanol and the combination provided immobilization superior to medetomidine sedation, thus better over all working conditions during intradermal testing compared to medetomidine. The study results indicate that dexmedetomidine and butorphanol sedation is very suitable for intradermal testing in dogs. SLU/Dept. of Clinical Sciences (until 231231) 2010 L3 swe eng https://stud.epsilon.slu.se/775/
spellingShingle Hund
Allergi
Atopisk dermatit
Atopi
Intradernaltest
Sedering
Dexmedetomidin
Butorfanol
Dahlheim, Anna
Effekter av sedering med dexmedetomidin och butorfanol på hudreaktivitet vid intradermaltest på friska hundar
title Effekter av sedering med dexmedetomidin och butorfanol på hudreaktivitet vid intradermaltest på friska hundar
title_full Effekter av sedering med dexmedetomidin och butorfanol på hudreaktivitet vid intradermaltest på friska hundar
title_fullStr Effekter av sedering med dexmedetomidin och butorfanol på hudreaktivitet vid intradermaltest på friska hundar
title_full_unstemmed Effekter av sedering med dexmedetomidin och butorfanol på hudreaktivitet vid intradermaltest på friska hundar
title_short Effekter av sedering med dexmedetomidin och butorfanol på hudreaktivitet vid intradermaltest på friska hundar
title_sort effekter av sedering med dexmedetomidin och butorfanol på hudreaktivitet vid intradermaltest på friska hundar
topic Hund
Allergi
Atopisk dermatit
Atopi
Intradernaltest
Sedering
Dexmedetomidin
Butorfanol